The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women
- 28 May 2002
- journal article
- review article
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 3 (1) , 53-63
- https://doi.org/10.1016/s1567-5688(01)00009-5
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- The effect of route of administration of hormone replacement therapy on cardiovascular risk factors in normal and type 2 diabetic womenPost Reproductive Health, 2000
- Hormone replacement therapy, cardiovascular risk factors and diabetesPost Reproductive Health, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal WomenNew England Journal of Medicine, 1997
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Postmenopausal use of estrogen and occlusion of coronary arteriesAmerican Heart Journal, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee.Circulation, 1979